Literature DB >> 3131156

Malignant schwannoma of the stomach in a patient with neurofibromatosis.

C S Gennatas1, G Exarhakos, A Kondi-Pafiti, D Kannas, G Athanassas, H D Politi.   

Abstract

Malignant schwannoma of the stomach is a rare neurogenic tumor. We report a case in a man with neurofibromatosis, who developed liver metastasis 1 year after excision of the tumor and died a few months later despite aggressive chemotherapy.

Entities:  

Mesh:

Year:  1988        PMID: 3131156

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature.

Authors:  Lysandra Voltaggio; Rebecca Murray; Jerzy Lasota; Markku Miettinen
Journal:  Hum Pathol       Date:  2011-12-01       Impact factor: 3.466

2.  Gastric Schwannoma: A Case Report and Review of Literature.

Authors:  M R Sreevathsa; Gotam Pipara
Journal:  Indian J Surg Oncol       Date:  2015-03-18

3.  Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.

Authors:  Shih-Ping Cheng; Ming-Jer Huang; Tsen-Long Yang; Chin-Yuan Tzen; Chien-Liang Liu; Tsang-Pai Liu; Shu-Ching Hsiao
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  What About Gastric Schwannoma? A Review Article.

Authors:  Sara Lauricella; Sergio Valeri; Gianluca Mascianà; Ida Francesca Gallo; Erica Mazzotta; Chiara Pagnoni; Saponaro Costanza; Lorenza Falcone; Domenico Benvenuto; Marco Caricato; Gabriella Teresa Capolupo
Journal:  J Gastrointest Cancer       Date:  2021-03

5.  Gastric schwannoma: a case report and literature review.

Authors:  S Atmatzidis; G Chatzimavroudis; D Dragoumis; P Tsiaousis; A Patsas; K Atmatzidis
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

6.  Neurofibromatosis 1 presenting with multiple duodenal GISTS associated with a somatostatin-producing D cell neoplasm.

Authors:  Giovanni Serio; Clementina Zampatti; Andrea Ballabio; Riccardo Ricci; Maurizio Martini; Francesco Zurleni
Journal:  Endocr Pathol       Date:  2013-06       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.